Turning the Key to Critical Limb Ischemia Therapy

elcome to the Critical Limb Ischemia Com- pendium, or CLIC, which was born out of the need to provide more in- formation to health care providers treating patients with critical limb ischemia (CLI), who are often left with minimal to no options for care. It is time to turn the key that opens the door to CLI therapy and just treat CLI. The time has come for vascular spe- cialists to create a movement in the implementation of therapeutic plans for CLI patients that includes prom- ising alternatives to amputation. The time has come to ask for more resourc- es, tools, data, medications, and systems of care for the sick CLI patient. The spectrum of presentation of CLI has changed and therefore it is time for CLI therapy goals to change. CLI used to be the disease of elderly and debilitated patients. This is no longer true. CLI is claim- ing younger patients every day and is reaching epidemic proportions. Given the predicted morbidity and mortality associated with CLI, vascular specialists, family physi- cians, podiatrists, and wound care specialists have to turn the key by using each of their educational backgrounds and clinical expe- rience to provide the level and spectrum of appropriate care these patients need. As the impact of this disease continues to broaden, so do the skills, tools, and medi- cines available to counter the pro- gressive stages of the disease. Each member of the team with his or her unique and varied skill set has something to contribute to the therapeutic algorithm of the CLI patient. So let's put our hands to- gether, unify directed efforts and "Just treat it!"

[1]  F. Vermassen,et al.  Drug-eluting balloon versus standard balloon angioplasty for infrapopliteal arterial revascularization in critical limb ischemia: 12-month results from the IN.PACT DEEP randomized trial. , 2014, Journal of the American College of Cardiology.

[2]  C. St. Hilaire,et al.  Medial vascular calcification revisited: review and perspectives. , 2014, European heart journal.

[3]  D. Scheinert,et al.  The LEVANT I (Lutonix paclitaxel-coated balloon for the prevention of femoropopliteal restenosis) trial for femoropopliteal revascularization: first-in-human randomized trial of low-dose drug-coated balloon versus uncoated balloon angioplasty. , 2014, JACC. Cardiovascular interventions.

[4]  I. Porto,et al.  Drug-Eluting Balloon in Peripheral Intervention for Below the Knee Angioplasty Evaluation (DEBATE-BTK): A Randomized Trial in Diabetic Patients With Critical Limb Ischemia , 2013, Circulation.

[5]  M. Makaroun,et al.  Predictors and outcomes of restenosis following tibial artery endovascular interventions for critical limb ischemia. , 2013, Journal of vascular surgery.

[6]  T. Albrecht,et al.  Drug-coated balloons and their place in treating peripheral arterial disease , 2013, Expert review of medical devices.

[7]  D. Scheinert,et al.  A prospective randomized multicenter comparison of balloon angioplasty and infrapopliteal stenting with the sirolimus-eluting stent in patients with ischemic peripheral arterial disease: 1-year results from the ACHILLES trial. , 2012, Journal of the American College of Cardiology.

[8]  T. Albrecht,et al.  Paclitaxel-Coated Balloons Reduce Restenosis After Femoro-Popliteal Angioplasty: Evidence From the Randomized PACIFIER Trial , 2012, Circulation. Cardiovascular interventions.

[9]  A. Cannavale,et al.  Lower Limb Multilevel Treatment With Drug-Eluting Balloons: 6-Month Results From the DEBELLUM Randomized Trial , 2012, Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists.

[10]  D. Scheinert,et al.  Randomized comparison of everolimus-eluting versus bare-metal stents in patients with critical limb ischemia and infrapopliteal arterial occlusive disease. , 2012, Journal of vascular surgery.

[11]  D. Scheinert,et al.  First experience with drug-eluting balloons in infrapopliteal arteries: restenosis rate and clinical outcome. , 2011, Journal of the American College of Cardiology.

[12]  G. Hubermont,et al.  A Reliable Approach to Diabetic Neuroischemic Foot Wounds: Below-the-Knee Angiosome-Oriented Angioplasty , 2011, Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists.

[13]  B. Cremers,et al.  Paclitaxel-coated balloons - Survey of preclinical data. , 2010, Minerva cardioangiologica.

[14]  G. Sangiorgi,et al.  Optimization of drug‐eluting balloon use for safety and efficacy: Evaluation of the 2nd generation paclitaxel‐eluting DIOR‐balloon in porcine coronary arteries , 2010, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[15]  S. Nanto,et al.  Importance of the angiosome concept for endovascular therapy in patients with critical limb ischemia , 2010, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[16]  E. Jude,et al.  Peripheral arterial disease in diabetes—a review , 2010, Diabetic medicine : a journal of the British Diabetic Association.

[17]  T. Zeller,et al.  Recanalization of chronic occlusions of the superficial femoral artery using the outback™ re‐entry catheter: A single centre experience , 2009, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[18]  B. Hamm,et al.  Inhibition of Restenosis in Femoropopliteal Arteries: Paclitaxel-Coated Versus Uncoated Balloon: Femoral Paclitaxel Randomized Pilot Trial , 2008, Circulation.

[19]  M. Romiti,et al.  Meta-analysis of infrapopliteal angioplasty for chronic critical limb ischemia. , 2008, Journal of vascular surgery.

[20]  K. Ouriel,et al.  Angiography Underestimates Peripheral Atherosclerosis: Lumenography Revisited , 2008, Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists.

[21]  L. Norgren,et al.  Inter-society consensus for the management of peripheral arterial disease. , 2007, International angiology : a journal of the International Union of Angiology.

[22]  L. Norgren,et al.  Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). , 2007, Journal of vascular surgery.

[23]  Johannes Lammer,et al.  Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. , 2006, The New England journal of medicine.

[24]  K. Johnston Femoral and popliteal arteries: reanalysis of results of balloon angioplasty. , 1992, Radiology.